Minireviews
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2013; 19(5): 654-664
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.654
Table 1 Cell culture systems and in vitro models developed to study hepatitis B virus and hepatitis C virus envelope glycoproteins
In vitromodel/cell culture systemStep of the viral cycleBenefits and major findingsDrawbacks
HBVPrimary hepatocyte culturesNot easy to handle
PHHReplicationNo need for DMSO and hydrocortisone for PTH systemCells cannot be propagated in vitro
PTHAddition of growth factors
Hepatic cell lines
HepG2Binding and infectionSpecific binding and uptakeNo productive infection
HepaRG(HBV and HDV)Cellular determinants of hepatocyte differentiation and their influence on HBV infectionAddition of DMSO and hydrocortisone
HCVRecombinant E2 glycoprotein: Truncated soluble form of recombinant E2 glycoproteinEntry processIdentification of two major receptors CD81 and SR-BIDifferent behavior from E1 E2 heterodimers
Interaction with heparan sulfate proteoglycansBinding to various cell lines different from hepatocytes
VLPs: Self assembly of HCV structural proteins produced in insect or mammalian cells using a recombinant virusEntry processE1–E2 heterodimers at virion surfaceDifference in glycosylation status
Cell attachmentDifficult to prepare
Attractive vaccine candidateNon replicative
HCVpp: Unmodified HCV envelope glycoproteins assembled onto retroviral or lentiviral core particlesEntry processStudy of infectivity and neutralizationOnly the very early steps of viral cycle
No association with lipoproteins
No budding at the ER
HCVcc: Transfection of one HCV strain sequence (JFH1) from a Japanese patient with fulminant hepatitis, in Huh 7 cell line.Entire life cycleEntry process +++Restricted to Huh-7 cell line
ReplicationRestricted to JFH1 non structural proteins sequence
Virus production
Screening of antiviral molecules